Abivax
(ABVX.FP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | |
| Cash Flows From Operating Activities | |
| Accounts payable and accrued liabilities | -4,268 |
| Other Operating Activity | 963 |
| Operating Cash Flow | $-3,305 |
| Cash Flows From Investing Activities | |
| Other Investing Activity | -43 |
| Investing Cash Flow | $-43 |
| Cash Flows From Financing Activities | |
| Debt Issued | 45 |
| Debt Repayment | -124 |
| Other Financing Activity | 6,020 |
| Financing Cash Flow | $5,941 |
| Beginning Cash Position | 40 |
| End Cash Position | 2,921 |
| Net Cash Flow | $2,593 |
| Free Cash Flow | |
| Operating Cash Flow | -3,305 |
| Capital Expenditure | -43 |
| Free Cash Flow | -3,348 |